Clinical Trial Detail

NCT ID NCT00978250
Title A Multi-Histology Phase II Study of 5-Fluoro-2-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lung non-small cell carcinoma

transitional cell carcinoma

head and neck cancer

breast cancer

Therapies

5-Fluoro-2-deoxycytidine + Tetrahydrouridine

Age Groups: adult

No variant requirements are available.